A detailed history of Invesco Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Invesco Ltd. holds 1,057,891 shares of RGEN stock, worth $167 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,057,891
Previous 1,307,034 19.06%
Holding current value
$167 Million
Previous $165 Million 4.45%
% of portfolio
0.03%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.79 - $167.35 $29.8 Million - $41.7 Million
-249,143 Reduced 19.06%
1,057,891 $157 Million
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $7.71 Million - $11.8 Million
64,291 Added 5.17%
1,307,034 $165 Million
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $70 Million - $85.4 Million
409,599 Added 49.16%
1,242,743 $229 Million
Q4 2023

Feb 12, 2024

BUY
$114.17 - $185.35 $14.4 Million - $23.4 Million
126,473 Added 17.9%
833,144 $150 Million
Q3 2023

Nov 13, 2023

BUY
$138.78 - $176.51 $4.24 Million - $5.4 Million
30,566 Added 4.52%
706,671 $112 Million
Q2 2023

Aug 11, 2023

SELL
$138.42 - $180.31 $98.8 Million - $129 Million
-713,881 Reduced 51.36%
676,105 $95.6 Million
Q1 2023

May 12, 2023

SELL
$154.26 - $198.1 $27.9 Million - $35.9 Million
-181,020 Reduced 11.52%
1,389,986 $234 Million
Q4 2022

Feb 13, 2023

SELL
$162.42 - $220.56 $45.5 Million - $61.8 Million
-280,265 Reduced 15.14%
1,571,006 $266 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $3.97 Million - $6.35 Million
-24,777 Reduced 1.32%
1,851,271 $346 Million
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $16.9 Million - $22.5 Million
119,891 Added 6.83%
1,876,048 $305 Million
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $10.6 Million - $16.9 Million
65,550 Added 3.88%
1,756,157 $330 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $111 Million - $136 Million
-446,775 Reduced 20.9%
1,690,607 $448 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $39.7 Million - $66 Million
-203,661 Reduced 8.7%
2,137,382 $618 Million
Q2 2021

Aug 17, 2021

BUY
$165.87 - $220.95 $7.82 Million - $10.4 Million
47,117 Added 2.05%
2,341,043 $467 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $34.2 Million - $42.9 Million
-189,570 Reduced 7.63%
2,293,926 $446 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $40.2 Million - $56.1 Million
271,701 Added 12.28%
2,483,496 $476 Million
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $27.8 Million - $35.9 Million
226,733 Added 11.42%
2,211,795 $326 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $31.7 Million - $47.2 Million
-335,782 Reduced 14.47%
1,985,062 $245 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $1.97 Million - $2.53 Million
-23,212 Reduced 0.99%
2,320,844 $224 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $15.1 Million - $19.1 Million
-204,788 Reduced 8.03%
2,344,056 $217 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $41.4 Million - $51.6 Million
-539,750 Reduced 17.48%
2,548,844 $195 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $58 Million - $91.9 Million
1,069,284 Added 52.95%
3,088,594 $265 Million
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $4.93 Million - $6.26 Million
-99,733 Reduced 4.71%
2,019,310 $119 Million
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $102 Million - $146 Million
2,119,043 New
2,119,043 $112 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.